{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT02334579",
            "orgStudyIdInfo": {
                "id": "IR 5642"
            },
            "organization": {
                "fullName": "Swedish Medical Center",
                "class": "OTHER"
            },
            "briefTitle": "Stereotactic Body Radiotherapy for Stage I-III Prostate Cancer",
            "officialTitle": "Function-Preserving Stereotactic Body Radiotherapy for Clinical State I-III Prostate Cancer",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "stereotactic-body-radiotherapy-for-stage-i-iii-prostate-cancer"
        },
        "statusModule": {
            "statusVerifiedDate": "2019-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2014-12"
            },
            "primaryCompletionDateStruct": {
                "date": "2023-12",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2014-12-04",
            "studyFirstSubmitQcDate": "2015-01-06",
            "studyFirstPostDateStruct": {
                "date": "2015-01-08",
                "type": "ESTIMATED"
            },
            "lastUpdateSubmitDate": "2019-07-11",
            "lastUpdatePostDateStruct": {
                "date": "2019-07-12",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Swedish Medical Center",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to find out the effects (good and bad) of highly focused radiation on you and your prostate cancer. The purpose of this evaluation is to see if this treatment causes fewer side effects that other standard treatment approaches, and to evaluate the effect of this treatment on your prostate tumor and your quality of life over time."
        },
        "conditionsModule": {
            "conditions": [
                "Prostate Cancer",
                "Prostatic Cancer",
                "Prostate Neoplasms",
                "Prostatic Neoplasms",
                "Cancer of the Prostate"
            ],
            "keywords": [
                "Radiation",
                "Stereotactic Radiosurgery",
                "Radiotherapy",
                "Prostate Tumor",
                "Prostate Surgery",
                "CyberKnife"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 146,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "CyberKnife Stereotactic Radiosurgery",
                    "type": "EXPERIMENTAL",
                    "description": "This treatment concentrates large doses of radiation onto the tumor so that injury from radiation to the nearby normal tissue will be minimal. CyberKnife Stereotactic Radiosurgery is not investigational and is considered standard of care.",
                    "interventionNames": [
                        "Radiation: CyberKnife Stereotactic Radiosurgery"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "RADIATION",
                    "name": "CyberKnife Stereotactic Radiosurgery",
                    "description": "Five treatments given over about one week.",
                    "armGroupLabels": [
                        "CyberKnife Stereotactic Radiosurgery"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Quality of life outcomes (low- and intermediate-risk prostate cancer groups)",
                    "description": "In the low- and intermediate-risk prostate cancer groups, to determine whether study treatment improves patient-reported quality of life outcomes compared to the approach used in a previous multi-center cyberknife stereotactic radiosurgery trial.",
                    "timeFrame": "8 years"
                },
                {
                    "measure": "Rates of acute and late grade 3-5 gastrointestinal and genitourinary toxicities (high-risk group)",
                    "description": "In the high-risk group, to estimate rates of acute and late grade 3-5 gastrointestinal and genitourinary toxicities following cyberknife stereotactic radiosurgery.",
                    "timeFrame": "8 years"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Rates of toxicities related to treatment",
                    "description": "After five years following cyberknife stereotactic radiosurgery, estimate rates of toxicities related to treatment.",
                    "timeFrame": "5 years"
                },
                {
                    "measure": "Disease free survival",
                    "description": "Measure disease free survival after five years following cyberknife stereotactic radiosurgery.",
                    "timeFrame": "5 years"
                },
                {
                    "measure": "Overall survival",
                    "description": "Measure overall survival after five years following cyberknife stereotactic radiosurgery.",
                    "timeFrame": "5 years"
                }
            ],
            "otherOutcomes": [
                {
                    "measure": "Quality of life",
                    "description": "Measure quality of life after five years following cyberknife stereotactic radiosurgery.",
                    "timeFrame": "5 years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Histologically proven prostate adenocarcinoma\n* Clinical stage T1a-T3, N0-Nx, M0-Mx\n* Patients belonging in one of the following risk groups: (1) LOW RISK: CS T1a-T2a, Gleason 2-6, PSA\\<10, Nx-0, Mx-0; (2) INTERMEDIATE RISK: CS T2b, Gleason \u22647, PSA\\<20, Nx-0, Mx-0, or CS T1a-T2b, Gleason 2-6, PSA\u226510 \\& \\<20, Nx-0, Mx-0, or CS T1a-T2b, Gleason 7, PSA\u226420, Nx-0, Mx-0; or (3) HIGH RISK: CS T2c-T3, any Gleason, any PSA, or CS T1-3, Gleason \u22658 and/or PSA\u226520\n* Karnofsky performance status 70-100\n* Hormone therapy: includes LHRH agonists (e.g. leuprolide, goserelin, triptorelin), antagonists (e.g. degarelix), peripheral blockers (e.g. flutamide, bicalutamide, nilutamide), estrogens (e.g. DES) and bilateral orchiectomy\n* Low and Intermediate risk groups: no hormone ablation for two months prior to enrollment, or during treatment\n* High risk group: three hormone therapy regimens are allowed\n* 5-alpha reductase inhibitors (e.g., finasteride or dutasteride) are allowed\n\nExclusion Criteria:\n\n* Prior prostatectomy or cryotherapy of the prostate\n* Prior high-dose radiotherapy to the prostate or lower pelvis\n* Implanted hardware or other material that would prohibit appropriate treatment planning or treatment delivery, in the investigator's opinion",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Mary Monahan",
                    "role": "CONTACT",
                    "phone": "(206) 320-7129",
                    "email": "mary.monahan@swedish.org"
                },
                {
                    "name": "Robert Meier, MD",
                    "role": "CONTACT",
                    "phone": "(206) 320-7130",
                    "email": "robert.meier@swedish.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Robert Meier, MD",
                    "affiliation": "Swedish Medical Center Radiosurgery Center",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Swedish Medical Center Radiosurgery Center",
                    "status": "RECRUITING",
                    "city": "Seattle",
                    "state": "Washington",
                    "zip": "98122",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Mary Monahan",
                            "role": "CONTACT",
                            "phone": "206-320-7029",
                            "email": "mary.monahan@swedish.org"
                        },
                        {
                            "name": "Robert Meier, MD",
                            "role": "CONTACT",
                            "phone": "(206) 320-7130",
                            "email": "robert.meier@swedish.org"
                        },
                        {
                            "name": "Robert Meier, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 47.60621,
                        "lon": -122.33207
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "Swedish Medical Center Radiosurgery Center",
                    "url": "http://www.swedish.org/services/radiosurgery-center"
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000011471",
                    "term": "Prostatic Neoplasms"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000005834",
                    "term": "Genital Neoplasms, Male"
                },
                {
                    "id": "D000014565",
                    "term": "Urogenital Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000005832",
                    "term": "Genital Diseases, Male"
                },
                {
                    "id": "D000091662",
                    "term": "Genital Diseases"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000011469",
                    "term": "Prostatic Diseases"
                },
                {
                    "id": "D000052801",
                    "term": "Male Urogenital Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M14335",
                    "name": "Prostatic Neoplasms",
                    "asFound": "Prostate Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8946",
                    "name": "Genital Neoplasms, Male",
                    "relevance": "LOW"
                },
                {
                    "id": "M17315",
                    "name": "Urogenital Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M2876",
                    "name": "Genital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8944",
                    "name": "Genital Diseases, Male",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14333",
                    "name": "Prostatic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27095",
                    "name": "Male Urogenital Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        }
    },
    "hasResults": false
}